+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hematological Drugs Market Research Reports

Thalassemia- Pipeline Insight, 2025 - Product Thumbnail Image

Thalassemia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Uncontrolled Bleeding - Pipeline Insight, 2025 - Product Thumbnail Image

Uncontrolled Bleeding - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Intracerebral Hemorrhage - Pipeline Insight, 2025 - Product Thumbnail Image

Intracerebral Hemorrhage - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Essential Thrombocythemia (ET) - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Essential Thrombocythemia (ET) - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • February 2025
  • 137 Pages
  • Global
From
Polycythemia Vera - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Polycythemia Vera - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • January 2025
  • 226 Pages
  • Global
From
Myelofibrosis (MF) - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Myelofibrosis (MF) - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • January 2025
  • 255 Pages
  • Global
From
Aplastic Anemia - Epidemiology Forecast - 2034 - Product Thumbnail Image

Aplastic Anemia - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 75 Pages
  • Global
From
Sickle Cell Disease - Epidemiology Forecast - 2034 - Product Thumbnail Image

Sickle Cell Disease - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 99 Pages
  • Global
From
Hemophilia A - Epidemiology Forecast - 2034 - Product Thumbnail Image

Hemophilia A - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 144 Pages
  • Global
From
Warm Autoimmune Hemolytic Anemia (WAIHA) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Warm Autoimmune Hemolytic Anemia (WAIHA) - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 67 Pages
  • Global
From
Diamond-Blackfan Anemia - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Diamond-Blackfan Anemia - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • September 2024
  • 95 Pages
  • Global
From
Hematological Disorders Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Thumbnail Image

Hematological Disorders Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • October 2024
  • 243 Pages
  • Global
From
2025 Tranexamic Acid Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032 - Product Thumbnail Image

2025 Tranexamic Acid Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032

  • Report
  • January 2025
  • 157 Pages
  • Global
From
2025 Microbial Coagulants Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032) - Product Thumbnail Image

2025 Microbial Coagulants Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032)

  • Report
  • January 2025
  • 146 Pages
  • Global
From
2025 Bovine Serum Albumin Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032) - Product Thumbnail Image

2025 Bovine Serum Albumin Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032)

  • Report
  • January 2025
  • 151 Pages
  • Global
From
Recombinant Coagulation Factors Market Outlook Report: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2034 - Product Thumbnail Image

Recombinant Coagulation Factors Market Outlook Report: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2034

  • Report
  • December 2024
  • 150 Pages
  • Global
From
Hyperuricemia Treatment Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Hyperuricemia Treatment Market - Forecasts from 2025 to 2030

  • Report
  • April 2025
  • 149 Pages
  • Global
From
Anti-Fibrinolytic Drug Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Anti-Fibrinolytic Drug Market - Forecasts from 2025 to 2030

  • Report
  • January 2025
  • 144 Pages
  • Global
From
Sickle Cell Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Thumbnail Image

Sickle Cell Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • May 2025
  • 115 Pages
  • Global
From
Renal Anemia Therapeutics Market 2025-2029 - Product Thumbnail Image

Renal Anemia Therapeutics Market 2025-2029

  • Report
  • June 2025
  • 210 Pages
  • Global
From
Loading Indicator

The Hematological Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat hematological diseases. These diseases include anemia, leukemia, lymphoma, and other blood disorders. Hematological drugs are used to treat a variety of conditions, including cancer, autoimmune diseases, and blood disorders. The hematological drugs market is composed of a variety of companies, including large pharmaceutical companies, biotechnology companies, and specialty drug companies. These companies develop and produce drugs to treat hematological diseases, as well as other conditions. Some of the major players in the hematological drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more